Somatropin pegol

Generic Name
Somatropin pegol
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1088845-67-3
Unique Ingredient Identifier
ZF7544FTQW
Background

Somatropin pegol is under investigation in clinical trial NCT00715689 (Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083).

Associated Conditions
-
Associated Therapies
-

Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

First Posted Date
2009-12-17
Last Posted Date
2017-02-09
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
56
Registration Number
NCT01034202
Locations
🇩🇰

Novo Nordisk Investigational Site, Hvidovre, Denmark

A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

First Posted Date
2009-07-10
Last Posted Date
2017-02-08
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
31
Registration Number
NCT00936403
Locations
🇬🇧

Novo Nordisk Investigational Site, Cambridge, United Kingdom

Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

First Posted Date
2008-07-25
Last Posted Date
2017-02-08
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
40
Registration Number
NCT00722540
Locations
🇩🇪

Novo Nordisk Investigational Site, Neuss, Germany

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

First Posted Date
2008-07-15
Last Posted Date
2017-02-08
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
33
Registration Number
NCT00715689
Locations
🇩🇰

Novo Nordisk Investigational Site, Århus C, Denmark

© Copyright 2024. All Rights Reserved by MedPath